Nurix Therapeutics NRIX
NASDAQ NRIX
$25.08 -0.43 (-1.69%)
As of: Oct 23, 2026 · 2:44 PM EDT

Nurix Therapeutics (NRIX) Net Shares Issued and Repurchased (2019 - 2026)

Updated

Nurix Therapeutics (NRIX) reported Net Shares Issued and Repurchased of $5.16 million for fiscal Q3 2026 (quarter ended Aug 31, 2026), up 346.7% from $1.16 million a year earlier.

Analysis

Nurix Therapeutics (NRIX) Net Shares Issued and Repurchased (2019 - 2026) Analysis & Trends

Over the twelve months ended Aug 31, 2026, Nurix Therapeutics' Net Shares Issued and Repurchased came in at $261.21 million, up 28.6% year-over-year; for FY2025 (ended Nov 30, 2025), it was $238.64 million, down 50.9% from FY2024.

  • Net Shares Issued and Repurchased has a five-year compound annual growth rate of 1.7% (FY2020 to FY2025).
  • By fiscal year, Net Shares Issued and Repurchased came in at $485.68 million in FY2024, $3.22 million in FY2023 (-97.3%), $117.19 million in FY2022 (-23.8%) and $153.88 million in FY2021 (-29.8%).
  • Five-year quarterly Net Shares Issued and Repurchased spans a low of -$135,000 in fiscal Q4 2022 and a high of $237.77 million in fiscal Q2 2024.
  • Year over year, Net Shares Issued and Repurchased gained in two of the last five quarters, with growth averaging 31.5%.
  • The high point for year-over-year Net Shares Issued and Repurchased in five years was fiscal Q3 2026 (growth of 346.7%); the low point was fiscal Q2 2025 (a decline of 100.0%).
  • Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $66,000 (Q2 2026), $19.98 million (Q1 2026) and $236.01 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued (Qtr)
1 Eli Lilly 1,124.12 Bn 1,092.71 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 634.38 Bn 554.24 Bn 17.30 Bn -966.00 Mn
3 AbbVie 505.39 Bn 478.50 Bn 12.70 Bn -9.00 Mn
4 Merck 357.36 Bn 311.74 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 290.21 Bn 254.20 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 265.21 Bn 238.89 Bn 12.86 Bn 6.00 Mn
7 Amgen 237.81 Bn 193.21 Bn 7.24 Bn -
8 Gilead Sciences 194.79 Bn 168.99 Bn 6.22 Bn -346.00 Mn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn -
10 Nurix Therapeutics 2.80 Bn 169.76 Mn - 5.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2026 5.16 Mn
May 31, 2026 66,000.00
Feb 28, 2026 19.98 Mn
Nov 30, 2025 236.01 Mn
Aug 31, 2025 1.16 Mn
May 31, 2025 6,000.00
Feb 28, 2025 1.47 Mn
Nov 30, 2024 200.52 Mn
Aug 31, 2024 45.77 Mn
May 31, 2024 237.77 Mn
Feb 29, 2024 1.62 Mn
Nov 30, 2023 7,000.00
Aug 31, 2023 1.70 Mn
May 31, 2023 25,000.00
Feb 28, 2023 1.48 Mn
Nov 30, 2022 -135,000.00
Aug 31, 2022 115.41 Mn
May 31, 2022 432,000.00
Feb 28, 2022 1.49 Mn
Nov 30, 2021 500,000.00
API Access

Nurix Therapeutics Net Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-shares-issued-and-repurchased&ticker=NRIX&period=max&api_key=YOUR_API_KEY